681809-00-7Relevant academic research and scientific papers
Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3
Roenn, Robert,Sabnis, Yogesh A.,Gossas, Thomas,Akerblom, Eva,Helena Danielson,Hallberg, Anders,Johansson, Anja
, p. 544 - 559 (2007/10/03)
The hepatitis C virus (HCV) NS3 protease has emerged as a promising anti-HCV drug target. Herein, we present an investigation of NS3 inhibitors comprising the acyl sulfonamide functionality. A series of tetra- and tripeptide based acyl sulfonamide inhibit
Substituted cycloalkyl P1' hepatitis C virus inhibitors
-
Page/Page column 71; 72, (2010/02/06)
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
